H. Bouchaab

Discipline

Economies et finances (3) Psychologie (1) Sciences de l'information et de la communication (1)

Type de document

Articles (19) Recensions (8)

Co-auteur

Date

Source

Mot-clé

Patients (14) Patients (14) Treatment (13) Human beings (9) Radiotherapy (8) maladie (7) Lungs (7) Cancer (7) Radiotherapy (7) maladie (7) thérapie (6) Therapeutics (6) Lungs--Cancer (6) oncologie (5) Diagnosis (5) Cancer (5) Inhibitors (5) Oncology (5) Months (5) Immunotherapy (5) Immunotherapy (5) temps (durée) (4) gestion (4) cancer (4) abords (agglomération) (4) survie (4) Tumors (4) Time (4) Survival (4) Population (4)

Documents écrit par H. Bouchaab (19) | parle de H. Bouchaab (0)

Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events.
A. Coukos et al.
Thérapies ciblées et carcinomes non à petites cellules : nouveautés [Targeted therapies and non-small cell carcinomas : novelties]
R. Stauber et al. (18 mai 2022)
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients.
M. Obeid et al. (1 mai 2022)
Verzögerte Diagnose eines Lungenkarzinoms, das sich als choroidale Metastase in einem COVID-19-Patienten präsentierte und am Anfang mit Osimertinib behandelt wurde [Delayed Diagnosis of Lung Carcinoma Presenting as Choroidal Metastasis in a COVID-19 Patient and Initially Treated with Osimertinib]
C.N. Haeller et al.
Oncologie [2021 Oncology update]
M.L. Meyer et al. (2 févr. 2022)
68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis.
S. Boughdad et al.
Is sleeve lobectomy safe after induction therapy?-a systematic review and meta-analysis.
L.E. Chriqui et al.
Stereotactic lung reirradiation for local relapse: A case series.
R. Kinj et al.
Suivi téléphonique des patients testés positifs au SARS-CoV-2 au Département d’oncologie du CHUV [Telephone follow-up of SARS-CoV-2 positive patients at the Oncology Department of Lausanne University Hospital]
J. Jankovic et al. (7 avr. 2021)
Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab.
W.A. Mampuya et al.
Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor-Related Cholangiohepatitis.
L. Moi et al.
Oncologie [2020 oncology update]
G. Dei Tos et al. (27 janv. 2021)
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.
A. Passaro et al.
Cancer du poumon à petites cellules : prise en charge et nouveautés [Small-cell lung cancer: management and novelties]
K. Abdelhamid et al. (27 mai 2020)
Curative management of a cardiac metastasis from lung cancer revealed by an electrical storm.
R. Jumeau et al.
Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study.
C. Pozzessere et al.
Isodose 20 Gy found as a threshold dose for radiation recall dermatitis.
N. Scher et al.
Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08).
A. Curioni-Fontecedro et al.
Multidisciplinary approach of lumbo-sacral chordoma: From oncological treatment to reconstructive surgery.
F. Garofalo et al. (2015)